Cardiovascular disease is associated withhigh-fat-diet-induced liver damage andup-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model

Clinical Science

Volumn 124, Issue 1, 2013, Pages 53-63

  Burgueño, Adriana L ^a   Gianotti, Tomas F ^a   Mansilla, Noelia G ^a   Pirola, Carlos J ^a   Sookoian, Silvia ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Arterial hypertension; Fatty liver; Hypoxia; Hypoxia inducible factor 1 ; Liver damage; Metabolic syndrome; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; NUCLEAR RECEPTOR NR1D1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIRTUIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; GLUCOSE; HYDRALAZINE; VASCULOTROPIN A;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY METABOLISM; FATTY LIVER; GLUCONEOGENESIS; LIPID DIET; LIPID STORAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER WEIGHT; NONHUMAN; NUCLEAR REPROGRAMMING; PERFUSION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RHYTHM; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; VASOCONSTRICTION; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; ENZYMOLOGY; HISTOLOGY; LIVER; MALE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING; WISTAR KYOTO RAT;

ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; DIET, HIGH-FAT; FATTY LIVER; GLUCOSE; HISTOLOGICAL TECHNIQUES; HYDRALAZINE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872196275     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120151     Document Type: Article

References (51)

1. Kotronen, A. and Yki-Jarvinen, H. (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler., Thromb., Vasc. Biol. 28, 27-38
2. Eckel, R. H., Grundy, S. M. and Zimmet, P. Z. (2005) The metabolic syndrome. Lancet 365, 1415-1428
3. Targher, G. and Arcaro, G. (2007) Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 191, 235-240
4. Sookoian, S. and Pirola, C. J. (2008) Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J. Hepatol. 49, 600-607
5. Sookoian, S., Castano, G. O., Burgueno, A. L., Rosselli, M. S., Gianotti, T. F., Mallardi, P., Martino, J. S. and Pirola, C. J. (2010) Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 209, 585-591
6. Sookoian, S., Gianotti, T. F., Rosselli, M. S., Burgueno, A. L., Castano, G. O. and Pirola, C. J. (2011) Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis 218, 378-385
7. Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Sr., Ellison, R. C. and Fox, C. S. (2008) Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135, 1935-1944
8. Bellentani, S., Bedogni, G. and Tiribelli, C. (2008) Liver and heart: a new link? J. Hepatol. 49, 300-302
9. Schindhelm, R. K., Dekker, J. M., Nijpels, G., Stehouwer, C. D., Bouter, L. M., Heine, R. J. and Diamant, M. (2007) Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn study. Diabet. Med. 24, 430-435
10. Schindhelm, R. K., Dekker, J. M., Nijpels, G., Bouter, L. M., Stehouwer, C. D., Heine, R. J. and Diamant, M. (2007) Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn study. Atherosclerosis 191, 391-396
11. Ramsay, L. E. (1977) Liver dysfunction in hypertension. Lancet ii, 111-114
12. Atanur, S. S., Birol, I., Guryev, V., Hirst, M., Hummel, O., Morrissey, C., Behmoaras, J., Fernandez-Suarez, X. M., Johnson, M. D., McLaren, W. M. et al. (2010) The genome sequence of the spontaneously hypertensive rat: Analysis and functional significance. Genome Res. 20, 791-803
13. Pravenec, M. and Kurtz, T. W. (2010) Recent advances in genetics of the spontaneously hypertensive rat. Curr. Hypertens. Rep. 12, 5-9
14. Pravenec, M., Zidek, V., Landa, V., Simakova, M., Mlejnek, P., Kazdova, L., Bila, V., Krenova, D. and Kren, V. (2004) Genetic analysis of 'metabolic syndrome' in the spontaneously hypertensive rat. Physiol Res. 53 (Suppl. 1), S15-S22
15. Sen, S., Tarazi, R. C., Khairallah, P. A. and Bumpus, F. M. (1974) Cardiac hypertrophy in spontaneously hypertensive rats. Circ. Res. 35, 775-781
16. Schuman, M. L., Landa, M. S., Toblli, J. E., Peres Diaz, L. S., Alvarez, A. L., Finkielman, S., Paz, L., Cao, G., Pirola, C. J. and Garcia, S. I. (2011) Cardiac thyrotropin-releasing hormone mediates left ventricular hypertrophy in spontaneously hypertensive rats. Hypertension 57, 103-109
17. Landa, M. S., Garcia, S. I., Schuman, M. L., Burgueno, A., Alvarez, A. L., Saravia, F. E., Gemma, C. and Pirola, C. J. (2007) Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat. Am. J. Physiol. Endocrinol. Metab. 292, E1388-E1394
18. Rosselli, M. S., Burgueno, A. L., Carabelli, J., Schuman, M., Pirola, C. J. and Sookoian, S. (2009) Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis 206, 119-126
19. Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A. and Bacon, B. R. (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467-2474
20. Sookoian, S., Fernandez, M. A. and Castano, G. (2005) Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. World J. Gastroenterol. 11, 7560-7563
21. Sambandam, N., Chen, X., Cam, M. C. and Rodrigues, B. (1997) Cardiac lipoprotein lipase in the spontaneously hypertensive rat. Cardiovasc. Res. 33, 460-468
22. Byrne, C. D. (2010) Hypoxia and non-alcoholic fatty liver disease. Clin. Sci. 118, 397-400
23. Piguet, A. C., Stroka, D., Zimmermann, A. and Dufour, J. F. (2010) Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clin. Sci. 118, 401-410
24. Taylor, C. T. and Colgan, S. P. (1999) Therapeutic targets for hypoxia-elicited pathways. Pharm. Res. 16, 1498-1505
25. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M. and Shimomura, I. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911
26. Eltzschig, H. K. and Carmeliet, P. (2011) Hypoxia and inflammation. N. Engl. J. Med. 364, 656-665
27. Maekawa, K., Liang, C. S., Tsui, A., Chen, B. T. and Kawashima, S. (1984) Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system. Circulation 70, 908-916
28. Michael, L. H. and Seidel, C. L. (1981) Hydralazine: effect on contraction mechanics of WKY and SHR rat heart muscle. Hypertension 3, 356-361
29. Semenza, G. L. (2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19, 176-182
30. Lim, J. H., Lee, Y. M., Chun, Y. S., Chen, J., Kim, J. E. and Park, J. W. (2010) Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1α. Mol. Cell 38, 864-878
31. Lu, H., Forbes, R. A. and Verma, A. (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 277, 23111-23115
32. Laurenti, G., Benedetti, E., D'Angelo, B., Cristiano, L., Cinque, B., Rahysi, S., Alecci, M., Ceru, M., Cifone, M., Galzio, R. et al. (2011) Hypoxia induces peroxisome proliferatoractivated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells. J. Cell. Biochem. 112, 3891-3901
33. Duez, H. and Staels, B. (2010) Nuclear receptors linking circadian rhythms and cardiometabolic control. Arterioscler. Thromb. Vasc. Biol. 30, 1529-1534
34. Okamoto, K., Aoki, K., Nosaka, S. and Fukushima, M. (1964) Cardiovascular diseases in the spontaneously hypertensive rat. Japn. Circ. J. 28, 943-952
35. McMahon, T. (1973) Size and shape in biology. Science 179, 1201-1204
36. Pineda, T., I, Gervois, P. and Staels, B. (1999) Peroxisome proliferator-activated receptor α in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 10, 151-159
37. Djouadi, F., Weinheimer, C. J., Saffitz, J. E., Pitchford, C., Bastin, J., Gonzalez, F. J. and Kelly, D. P. (1998) A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor α- deficient mice. J. Clin. Invest. 102, 1083-1091
38. Finck, B. N. and Kelly, D. P. (2002) Peroxisome proliferator-activated receptor α (PPARα) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J. Mol. Cell. Cardiol. 34, 1249-1257
39. Schupp, M., Kintscher, U., Fielitz, J., Thomas, J., Pregla, R., Hetzer, R., Unger, T. and Regitz-Zagrosek, V. (2006) Cardiac PPARα expression in patients with dilated cardiomyopathy. Eur. J. Heart Failure 8, 290-294
40. Diep, Q. N. and Schiffrin, E. L. (2001) Increased expression of peroxisome proliferator-activated receptor-α and -γ in blood vessels of spontaneously hypertensive rats. Hypertension 38, 249-254
41. Duez, H. and Staels, B. (2008) The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism. Diab. Vasc. Dis. Res. 5, 82-88
42. Cui, H., Kohsaka, A., Waki, H., Bhuiyan, M. E., Gouraud, S. S. and Maeda, M. (2011) Metabolic cycles are linked to the cardiovascular diurnal rhythm in rats with essential hypertension. PLoS ONE 6, e17339
43. Bonapace, S., Perseghin, G., Molon, G., Canali, G., Bertolini, L., Zoppini, G., Barbieri, E. and Targher, G. (2012) Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 35, 389-395
44. Fallo, F., Dalla, P. A., Sonino, N., Lupia, M., Tona, F., Federspil, G., Ermani, M., Catena, C., Soardo, G., Di, P. L. et al. (2009) Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr. Metab. Cardiovasc. Dis. 19, 646-653
45. Fotbolcu, H., Yakar, T., Duman, D., Karaahmet, T., Tigen, K., Cevik, C., Kurtoglu, U. and Dindar, I. (2010) Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol. J. 17, 457-463
46. Goland, S., Shimoni, S., Zornitzki, T., Knobler, H., Azoulai, O., Lutaty, G., Melzer, E., Orr, A., Caspi, A. and Malnick, S. (2006) Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J. Clin. Gastroenterol. 40, 949-955
47. Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., Cigolini, M., Falezza, G. and Arcaro, G. (2006) Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 29, 1325-1330
48. Monteiro, J. P. and Cano, M. I. (2011) SIRT1 deacetylase activity and the maintenance of protein homeostasis in response to stress: an overview. Protein Pept. Lett. 18, 167-173
49. Westerheide, S. D., Anckar, J., Stevens, S. M., Jr., Sistonen, L. and Morimoto, R. I. (2009) Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323, 1063-1066
50. Im, S. S., Kim, M. Y., Kwon, S. K., Kim, T. H., Bae, J. S., Kim, H., Kim, K. S., Oh, G. T. and Ahn, Y. H. (2011) Peroxisome proliferator-activated receptor α is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db mice. J. Biol. Chem. 286, 1157-1164
51. + -dependent protein deacetylase, via activation of PPARα in mice. Mol. Cell. Biochem. 339, 285-292